Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
NCT05667064
·
clinicaltrials.gov ↗
COMPLETED
Status
1200
Enrollment
INDUSTRY
Sponsor class
Conditions
Unresectable Hepatocellular Carcinoma
Sponsor
AstraZeneca